Juno Therapeutics, Inc. and Its CEO Sued for Securities Fraud by Block & Leviton LLP BOSTON, July 15, 2016 (GLOBE NEWSWIRE) -- Juno Therapeutics, Inc. (“Juno” or the “Company”) (NASDAQ:JUNO) and its chief executive officer, Hans E. Bishop, were named as defendants in a lawsuit filed...